2022 Parainfluenza Virus Infection Pipeline Insights: Featuring AlloVir, Ansun Biopharma and Moderna Therapeutics
February 08, 2023 13:18 ET
|
Research and Markets
Dublin, Feb. 08, 2023 (GLOBE NEWSWIRE) -- The "Parainfluenza Virus Infection - Pipeline Insight, 2022" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides...
Carbapenem-Resistant Enterobacteriaceae Infection Market Research Report 2021: Marketed Products, Emerging Therapies, Major Markets, Epidemiology
August 09, 2021 04:33 ET
|
Research and Markets
Dublin, Aug. 09, 2021 (GLOBE NEWSWIRE) -- The "Carbapenem-Resistant Enterobacteriaceae Infection - Market Insight, Epidemiology and Market Forecast - 2030" report has been added to...
United States Methicillin Resistant Staphylococcus Aureus (MRSA) Infections Market and Competitive Landscape Report 2021
January 19, 2021 04:08 ET
|
Research and Markets
Dublin, Jan. 19, 2021 (GLOBE NEWSWIRE) -- The "US Methicillin Resistant Staphylococcus Aureus Infections Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's...
2020 Outlook on Complicated Urinary Tract Infections - Players Include Entasis Therapeutics & Locus Biosciences
December 16, 2020 10:13 ET
|
Research and Markets
Dublin, Dec. 16, 2020 (GLOBE NEWSWIRE) -- The "Complicated Urinary Tract Infections- Pipeline Insight, 2020" drug pipelines has been added to ResearchAndMarkets.com's offering. This report...
2020 Global Chlamydia Infections Pipeline Review
November 03, 2020 12:38 ET
|
Research and Markets
Dublin, Nov. 03, 2020 (GLOBE NEWSWIRE) -- The "Chlamydia Infections - Pipeline Review, H2 2020" drug pipelines has been added to ResearchAndMarkets.com's offering. This guide provides comprehensive...